{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T04:26:03Z","timestamp":1770956763972,"version":"3.50.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12,1]]},"DOI":"10.1097\/qai.0b013e318158c0a6","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T23:43:42Z","timestamp":1236123822000},"page":"451-455","source":"Crossref","is-referenced-by-count":85,"title":["Metabolic Function and the Prevalence of Lipodystrophy in a Population of HIV-Infected African Subjects Receiving Highly Active Antiretroviral Therapy"],"prefix":"10.1097","volume":"46","author":[{"given":"Eugene","family":"Mutimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimee","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Rheeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel John","family":"Crowther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210131","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R2-11-20210131","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults.","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"R3-11-20210131","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/01.aids.0000237365.18747.13","article-title":"National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?","volume":"11","author":"Beck","year":"2006","journal-title":"AIDS"},{"key":"R4-11-20210131","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1097\/00002030-200112070-00012","article-title":"Failure to maintain long term adherence to highly active retroviral therapy: the role of lipodystrophy.","volume":"15","author":"Duran","year":"2001","journal-title":"AIDS"},{"key":"R5-11-20210131","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population.","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"R6-11-20210131","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","article-title":"An objective case definition of lipodystrophy in HIV-infected adults: a case-control study.","volume":"361","author":"Carr","year":"2003","journal-title":"Lancet"},{"key":"R7-11-20210131","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"R8-11-20210131","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"R9-11-20210131","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus.","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care"},{"key":"R10-11-20210131","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R11-11-20210131","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1097\/00002030-200010200-00025","article-title":"Lipodystrophy following antiretroviral therapy of primary HIV infection.","volume":"14","author":"Miller","year":"2000","journal-title":"AIDS"},{"key":"R12-11-20210131","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00126334-200312150-00003","article-title":"Incidence of lipoatrophy and lipohypertrophy in the Womens Interagency HIV Study.","volume":"34","author":"Tien","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R13-11-20210131","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1468-1293.2001.00073.x","article-title":"The prevalence of lipodystrophy in an ambulant HIV-infected population: it all depends on the definition.","volume":"2","author":"Carter","year":"2001","journal-title":"HIV Med"},{"key":"R14-11-20210131","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/135965350601100205","article-title":"Evaluation of the HIV lipodystrophy case definition in a placebo-controlled, 144-week study in antiretroviral-naive adults.","volume":"11","author":"Law","year":"2006","journal-title":"Antivir Ther"},{"key":"R15-11-20210131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000182230.47819.aa","article-title":"Study of fat redistribution and metabolic change in HIV infection (FRAM). Fat distribution in men with HIV infection.","volume":"40","author":"Bacchetti","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R16-11-20210131","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.qai.0000229996.75116.da","article-title":"Fat distribution in women with HIV infection.","volume":"42","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R17-11-20210131","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1089\/aid.2006.22.830","article-title":"Association between physical and echographic fat thickness assessments and a lipodystrophy grading scale in lipodystrophic HIV patients: their practical implications.","volume":"22","author":"Asensi","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R18-11-20210131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00001432-200402000-00005","article-title":"What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection.","volume":"17","author":"Tien","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"R19-11-20210131","first-page":"199","article-title":"Lipodystrophy and dyslipidaemia among patients taking first-line World Health Organization-recommended highly active antiretroviral therapy regimens in western India.","volume":"39","author":"Pujari","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R20-11-20210131","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-199903110-00004","article-title":"Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy.","volume":"13","author":"Gervasoni","year":"1999","journal-title":"AIDS"},{"key":"R21-11-20210131","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1086\/338811","article-title":"Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients.","volume":"34","author":"Chene","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R22-11-20210131","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/01.qai.0000214811.72916.67","article-title":"Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial.","volume":"41","author":"Mulligan","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-11-20210131","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1464-2662.2001.00100.x","article-title":"Risk factors for HIV-associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatment.","volume":"3","author":"Mauss","year":"2002","journal-title":"HIV Med"},{"key":"R24-11-20210131","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2165\/00002018-200528120-00002","article-title":"Do non-nucleoside reverse transcriptase inhibitors contribute to lipodystrophy?","volume":"28","author":"Nolan","year":"2005","journal-title":"Drug Saf"},{"key":"R25-11-20210131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/sti.2006.019588","article-title":"Current trends in Rwandas HIV\/AIDS epidemic.","volume":"82","author":"Kayirangwa","year":"2006","journal-title":"Sex Transm Infect"},{"key":"R26-11-20210131","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00126334-200309010-00008","article-title":"Gender differences in antiretroviral drug-related adipose tissue alterations: women are at higher risk than men and develop particular lipodystrophy patterns.","volume":"34","author":"Galli","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R27-11-20210131","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/135965350300800409","article-title":"Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.","volume":"8","author":"Pace","year":"2003","journal-title":"Antivir Ther"},{"key":"R28-11-20210131","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00002030-200306130-00007","article-title":"Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.","volume":"17","author":"Nolan","year":"2003","journal-title":"AIDS"},{"key":"R29-11-20210131","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/135965350501000105","article-title":"Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV Cohort Study.","volume":"10","author":"Young","year":"2005","journal-title":"Antivir Ther"},{"key":"R30-11-20210131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"903 Study Group. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"R31-11-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00042560-200201010-00003","article-title":"Body habitus changes and metabolic alterations in protease inhibitor-naive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitors.","volume":"29","author":"Galli","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R32-11-20210131","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/01.aids.0000181011.62385.91","article-title":"Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study.","volume":"19","author":"Brown","year":"2005","journal-title":"AIDS"},{"key":"R33-11-20210131","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","article-title":"Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.","volume":"348","author":"Bozette","year":"2003","journal-title":"N Engl J Med"},{"key":"R34-11-20210131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(04)16586-0","article-title":"Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.","volume":"364","author":"Laurent","year":"2004","journal-title":"Lancet"},{"key":"R35-11-20210131","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1468-1293.2005.00338.x","article-title":"Antiviral efficacy and resistance in patients on antiretroviral therapy in Kigali, Rwanda: the real-life situation in 2002.","volume":"7","author":"Fischer","year":"2006","journal-title":"HIV Med"},{"key":"R36-11-20210131","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1097\/01.aids.0000247580.16073.1b","article-title":"Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda.","volume":"20","author":"Au","year":"2006","journal-title":"AIDS"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-200712010-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:27Z","timestamp":1738972827000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200712010-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,1]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318158c0a6","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12,1]]}}}